Sort
51,593 grants matching “hepatitis”
Novel Mechanisms Regulating the Adipocyte-Brain Hepatocyte Axis
$1,510,882Philipp E Scherer · Ut Southwestern Medical Center · P01 · FY2012 · DK
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU
$1,510,774University Of Puerto Rico Med Sciences · U01 · FY2001 · AI
Molecular Toxicology of DNA Adducts
$1,507,845Arthur P Grollman · State University New York Stony Brook · P01 · FY2007 · ES
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)
$1,506,528Robert L. Murphy · Northwestern University · U54 · FY2019 · EB
Innate Immune Antivirals for Biodefense
$1,506,330Michael J Gale · University Of Washington · R01 · FY2012 · AI
Reinvigorating HIV Prevention and Care for People Who Use Drugs: Accelerating Progress and Sustaining Gains in the Midst of Societal Disruption
$1,506,082Don C Des Jarlais · New York University · P30 · FY2023 · DA
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$1,506,029Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2016 · MH
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2018 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2020 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2022 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2019 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2021 · DK
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$1,504,722Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2017 · MH
Anti-norovirus protease inhibitors for immunocompromised patients
$1,504,695Raymond F. Schinazi · Emory University · R01 · FY2025 · AI
RECODE: Real-time analysis and environmental feedback for directed differentiation of liver organoids
$1,504,585Sarah C Heilshorn · Stanford University · · FY2021 · ENG
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies
$1,504,401Bryan Lau · Johns Hopkins University · R01 · FY2025 · AI
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
$1,504,126Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · R01 · FY2012 · HL
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$1,502,802Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2019 · MH
North American AIDS Cohorts Collaboration on Research and Design
$1,502,251Richard Douglas Moore · Johns Hopkins University · U01 · FY2009 · AI
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,501,740University Of Miami School Of Medicine · U01 · FY2003 · AI
Role of Tim Family Genes in Asthma and Allergic Diseases
$1,500,346Dale T Umetsu · Boston Children'S Hospital · P01 · FY2006 · AI
California-Arizona Clinical Trials Network Node
$1,500,000University Of California San Francisco · U10 · FY2004 · DA
California-Arizona Clinical Trials Network Node
$1,500,000University Of California San Francisco · U10 · FY2003 · DA
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,500,000Steven E Shoelson · Joslin Diabetes Center · U01 · FY2010 · DK
Dev & Testing of New Medications for Treatment of Emerging Infectious Diseases
$1,500,000Mitchell Allen Avery · University Of Mississippi · U01 · FY2006 · CI